82
Views
2
CrossRef citations to date
0
Altmetric
Review

Acute stroke hypertension: current and future management

, , &
Pages 405-412 | Published online: 10 Jan 2014

References

  • Murray C, Lopez A. Alternative projections of mortality and disability by cause 1990–2020: global burden of disease study. Lancet 349, 1498–1504 (1997).
  • Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360, 1903–1913 (2002).
  • Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of different blood pressure-lowering regimens on major cardiovascular events: results of prospectively designed overviews of randomized trials. Lancet 362, 1527–1535 (2003).
  • Robinson TG. Hypertension and the Brain. In: Hypertension: Principles and Practice. Battegay E, Lip G, Bakris G (Eds.). Marcel Dekker, NY, USA (2005) (In Press).
  • International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomized trial of aspirin, subcutaneous heparin, both or neither among 19,435 patients with acute ischemic stroke. Lancet 349, 1569–1581 (1997).
  • CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomized placebo-controlled trial of early aspirin use on 20,000 patients with acute ischemic stroke. Lancet 349, 1641–1649 (1997).
  • Leonardi-Bee J, Bath P, Phillips S, Sandercock P, for the IST Collaborative Group. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 33, 1315–1320 (2002).
  • Lindley RI, Amayo EO, Marshall J et al. Acute stroke treatment in UK hospitals: the Stroke Association survey of consultant opinion. J. R. Coll. Physicians Lond.29, 479–484 (1995).
  • Boiser JC, Lichtman J, Cerese J, Brass LM. Treatment of hypertension in acute ischemic stroke: The University Health Consortium Benchmarking Project. Stroke 29, 305 (1998).
  • Robinson TG, Potter JF. Blood pressure in acute stroke. Age Ageing 33, 6–12 (2004).
  • Willmot M, Leonardi-Bee J, Bath P. High blood pressure in acute stroke and subsequent outcome. A systematic review. Hypertension 43, 18–24 (2004).
  • Britton M, Carlsson A, de Faire U. Blood pressure course in patients with acute stroke and matched controls. Stroke 17, 861–864 (1986).
  • Dawson S, Blake M, Panerai R, Potter J. Dynamic but not static cerebral autoregulation is impaired in acute ischemic stroke. Cerebrovasc. Dis. 10, 16–132 (2000).
  • Barer D, Cruickshank J, Ebrahim S, Mitchell J. Low-dose β-blockade in acute stroke (BEST trial): an evaluation. Br. Med. J.296, 737–741 (1988).
  • Horn J, Limburg M. Calcium antagonists for ischemic stroke. A systematic review. Stroke 32, 570–576 (2001).
  • Makatas F, Waechter R, Ebis G. Relation between cerebral perfusion pressure and arterial pressure in cerebral oedema. Lancet I, 684 (1972).
  • Waldemar G, Vorstrup S, Andersen A, Pedersen H, Paulson O. Angiotensin-converting enzyme inhibition and regional cerebral blood flow in acute stroke. J. Cardiovasc. Pharmacol. 14, 722–729 (1989).
  • Walters M, Bolster A, Dyker A, Lees K. Effect of perindopril on cerebral and renal perfusion in stroke patients with carotid disease. Stroke 32, 473–478 (2001).
  • Dyker A, Grosset D, Lees K. Perindopril reduces blood pressure but not cerebral blood flow in patients with recent ischemic stroke. Stroke 28, 580–583 (1997).
  • Schrader J, Luders S, Kulschewski A et al., on behalf of the ACCESS Study Group. The ACCESS Study. Evaluation of acute candesartan cilexetil therapy in stroke survivors. Stroke 34, 1699–1703 (2003).
  • Ahmed N, Nasman P, Wahlgren N. Effect of intravenous nimodipine on blood pressure and outcome after acute stroke. Stroke 31, 1250–1255 (2000).
  • Butterworth R, Cluckie A, Jackson S, Buxton-Thomas M, Bath P. Pathophysiological assessment of nitric oxide (given as sodium nitroprusside) in acute ischemic stroke. Cerebrovasc. Dis.8, 158–165 (1998).
  • Bath P, Pathansali R, Iddenden R, Bath F. The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovasc. Dis. 11, 265–272 (2001).
  • Eames PJ, Panerai RB, Robinson TG, Potter JF. Bendrofluazide fails to reduce elevated blood pressure levels in the immediate poststroke period. Cerebrovasc. Dis. 19, 253–259 (2005).
  • Eames PJ, Robinson TG, Panerai RB, Potter JF. The systemic haemodynamic and cerebral autoregulatory effects of bendrofluazide in the subacute poststroke period. J. Hypertens. 22, 2017–2024 (2004).
  • MacCarthy E, Bloomfield S. Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects. Pharmacotherapy 3, 193–219 (1983).
  • Brott T, Lu M, Kothari R et al., for the NINDS rt-PA Stroke Study Group. Hypertension and its treatment in the NINDS rt-PA stroke trial. Stroke 29, 1504–1509 (1998).
  • Intravenous Magnesium Efficacy in Stroke (IMAGES) Study Investigators. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomized controlled trial. Lancet 363, 439–445 (2004).
  • Rordorf G, Koroshetz W, Ezzeddine M, Segal A, Buonanno F. A pilot study of drug-induced hypertension for treatment of acute stroke. Neurology 56, 1210–1213 (2001).
  • Marzan A, Hungerbuhler H, Studer A, Baumgartner R, Georgiadis D. Feasibility and safety of norepinephrine-induced hypertension in acute ischemic stroke. Neurology 62, 1193–1195 (2004).
  • Royal College of Physicians. National Clinical Guidelines for Stroke. 2nd Edition. Royal College of Physicians, London, UK (2004).
  • Bath P, Weaver C, Iddenden R, Bath F. A trial of blood pressure reduction in acute stroke. Age Ageing 29, 554–555 (2000).
  • Gariballa SE, Robinson TG, Parker SG, Castleden CM. A prospective study of primary and secondary risk factor management in stroke patients. J. R. Coll. Physicians 29, 485–487 (1995).
  • The COSSACS Trial Group. COSSACS (Continue or Stop post-Stroke Antihypertensives Collaborative Study): rationale and design. J. Hypertens. 23, 455–458 (2005).
  • The CHHIPS Trial Group. CHHIPS (Controlling Hypertension and Hypotension Immediately Post-Stroke): rationale and design. J. Hypertens. 23, 649–655 (2005).
  • Bath P, Willmot M, Weaver C, Leonardi-Bee J. Efficacy of nitric oxide in stroke (ENOS) trial – a prospective randomized controlled trial in acute stroke. Cerebrovasc. Dis.13(Suppl. 3), 79 (2002).
  • The European Stroke Initiative Executive Committee and the EUSI Writing Committee. European Stroke Initiative Recommendations for Stroke Management – Update 2003. Cerebrovasc. Dis. 16, 311–337 (2003).
  • Adams H, Adams R, Brott T et al. Guidelines for the early management of patients with ischemic stroke. A scientific statement from the Stroke Council of the American Stroke Association. Stroke 34, 1056–1083 (2003).
  • The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 333, 1581–1587 (1995).

Websites

  • COSSACS Study www.le.ac.uk/COSSACS/COSSACShome.html (Accessed April 2005)
  • CHHIPS Study www.le.ac.uk/CHHIPS/HomePage.html (Accessed April 2005)
  • Efficacy of Nitric Oxide in Stroke trial www.enos.ac.uk (Accessed April 2005)

Patents

  • Blood Pressure in Acute Stroke Collaboration. Interventions for deliberately altering blood pressure in acute stroke. The Cochrane Database of Systematic Reviews 2001, Issue 2. Art. No.: CD000039. DOI: 10.1002/14651858.CD000039.
  • Blood Pressure in Acute Stroke Collaboration. Vasoactive drugs for acute stroke. The Cochrane Database of Systematic Reviews 2000, Issue 3. Art. No.: CD002839. DOI: 10.1002/14651858.CD002839.
  • Horn J, Limburg M. Calcium antagonists for acute ischemic stroke. The Cochrane Database of Systematic Reviews 2000, Issue 1. Art. No.: CD001928. DOI: 10–1002/14651858.CD001928.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.